---
title: "NVCR SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for NovoCure (NVCR), with links to the SEC filings."
url: "https://tradytics.com/research/NVCR/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=NVCR&v=stock-11994868"
---

# NVCR financial statements and SEC filings

## NVCR annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $655.35M | -$153.80M | -$136.23M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2024-12-31 | $605.22M | -$170.50M | -$168.63M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2023-12-31 | $509.34M | -$232.87M | -$207.04M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2022-12-31 | $537.84M | -$89.52M | -$92.53M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511325000002/0001645113-25-000002-index.htm) |
| 2021-12-31 | $535.03M | -$44.33M | -$58.35M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511324000006/0001645113-24-000006-index.htm) |
| 2020-12-31 | $494.37M | $30.40M | $19.81M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511323000023/0001645113-23-000023-index.htm) |

## NVCR annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $804.33M | $463.86M | $340.47M | [10-Q](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000080/0001645113-26-000080-index.htm) |
| 2024-12-31 | $1.24B | $880.61M | $360.18M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2023-12-31 | $1.15B | $783.63M | $362.50M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511325000002/0001645113-25-000002-index.htm) |
| 2022-12-31 | $1.19B | $750.48M | $441.17M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511324000006/0001645113-24-000006-index.htm) |
| 2021-12-31 | $1.14B | $729.00M | $410.49M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511323000023/0001645113-23-000023-index.htm) |
| 2020-12-31 | $1.05B | $575.46M | $476.53M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511322000011/0001645113-22-000011-index.htm) |

## NVCR annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$49.03M | -$26.65M | -$451.34M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2024-12-31 | -$26.37M | -$42.85M | $90.31M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2023-12-31 | -$73.34M | -$27.09M | $15.79M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511326000017/0001645113-26-000017-index.htm) |
| 2022-12-31 | $30.79M | -$21.36M | $15.49M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511325000002/0001645113-25-000002-index.htm) |
| 2021-12-31 | $82.76M | -$24.17M | $25.70M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511324000006/0001645113-24-000006-index.htm) |
| 2020-12-31 | $99.15M | -$14.97M | $440.21M | [10-K](https://www.sec.gov/Archives/edgar/data/1645113/000164511323000023/0001645113-23-000023-index.htm) |

- [NVCR stock research](https://tradytics.com/research/NVCR)
- [NVCR financial summary](https://tradytics.com/research/NVCR/financials)
- [Read the data without JavaScript](https://tradytics.com/research/NVCR/fundamentals?snapshot=1)
